Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Acoustic MedSystems and MRI Interventions develop ultrasonic ablation therapies for pancreatic cancer

Executive Summary

Acoustic MedSystems Inc. and MRI Interventions Inc. agreed to use each other’s technologies to develop new MRI-guided ultrasonic ablation therapies for pancreatic cancer.
Deal Industry
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • MRI, NMR
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing
    • Includes Equity
    • Includes Contract

Related Companies

Advertisement
UsernamePublicRestriction

Register